Aura Renew Acq Regulatory News (ARA)

28 Sep 2006 11:16

Ardana PLC28 September 2006 Ardana plc 28 September 2006 Ardana plc (the "Company") Annual Information Update This annual information update is filed pursuant to Prospectus Rule 5.2 made bythe Financial Services Authority and not for any other purpose and by filingthis annual information update neither the Company, nor any other person, takesany responsibility for, or makes any representation, express or implied, as tothe accuracy or completeness of, the information contained or referred to belowherein. The information referred to below is not necessarily up to date as atthe date of this annual information update and the Company does not undertakeany obligation to update any such information in the future. Furthermore, suchinformation may have been prepared in accordance with the laws or regulations ofa particular jurisdiction and may not comply with or meet the relevant standardsof disclosure in any other jurisdiction. Neither this annual information update,nor the information referred to below constitutes, by virtue of thiscommunication, an offer of any securities addressed to any person and should notbe relied on by any person. (1) Announcements made via a Regulatory Information Service Date Brief description 20 September 2006 Announcement of proposed Placing and Open Offer of New Ordinary Shares 13 September 2006 Notification of submission to UK Listing Authority of Annual Report & Accounts 11 September 2006 Announcement of results in clinical trial for Testosterone Cream 07 September 2006 Announcement of results in clinical trial for Teverelix Long Acting in endometriosis 31 August 2006 Notice of grant of US patent 29 June 2006 Preliminary Results Announcement for the year ended 31 March 2006 29 June 2006 Appointment of Non-Executive Director 14 June 2006 Notification of Preliminary Results 16 May 2006 Announcement of holding in company 12 May 2006 Announcement of holding in company 03 May 2006 Announcement of application for block listing 12 April 2006 Announcement of results in clinical trial for Testosterone Cream 17 March 2006 Appointment of VP Sales & Marketing 16 March 2006 Announcement of holding in company 14 March 2006 Announcement of holding in company 31 January 2006 Update from meeting with US Food & Drug Administration for Testosterone Cream 13 December 2005' Announcement of Interim Financial Results for the six months ended 30 September 2005 09 November 2005 Announcement of agreement with Nordic partner for Striant(TM) SR 31 October 2005 Announcement of results in clinical trial for Testosterone Cream 28 October 2005 Announcement of holding in company 05 October 2005 Announcement of launch of Striant(TM) SR in Germany Copies of the above announcements can be downloaded from the Company's pages ofthe London Stock Exchange website (www.londonstockexchange.com). (2) Documents filed at Companies House All of the documents listed below were filed with Companies House on or aroundthe dates indicated. Date Brief description 27 July 2006 Appointment of Director 01 December 2005 Annual Return made up to 10 November 2005 15 November 2005 Form 288c change of director's particulars Copies of documents filed at Companies House are available at Companies Housewhose website address is www.companieshouse.gov.uk or at the following addressCompanies House, Crown Way, Maindy, Cardiff CF14 3UZ. (3) Documents published or sent to shareholders or filed with the UKLA Viewing Facility Date Brief description 20 September 2006 Proposed Placing and Open Offer, and Notice of Extraordinary General Meeting 13 September 2006 Annual Report and Accounts for the ended 31 March 2006 13 September 2006 Letter to Shareholders and Notice of Annual General Meeting Copies of all the above the documents can be obtained from the Company Secretary. For further information contact: Graham Lee Company Secretary Tel. No. 0131 226 8550 Ardana plc 38 Melville Street Edinburgh EH3 7HA This information is provided by RNS The company news service from the London Stock Exchange